Last 12 months
Inside the activity.
0 purchase rows · 18 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 14, 2018 Filed Dec 18, 2018 22:29 UTC |
MCGUIRE TERRANCEDirector
|
GrantClass A Common Stock | 212 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-063262 · doc4.xml · nonDerivative · entry 1 MCGUIRE TERRANCE · CIK 0001117003 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,503 F1 · kind: Issued pursuant to the Director Compensation Plan, effective as of January 2014. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 22:28 UTC |
SCHULMAN AMY WDirector
|
GrantClass A Common Stock | 212 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-063261 · doc4.xml · nonDerivative · entry 1 SCHULMAN AMY W · CIK 0001438226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,115 F1 · kind: Issued pursuant to the Director Compensation Plan, effective as of January 2014. Read SEC document |
| December 06, 2018 Filed Dec 10, 2018 21:56 UTC |
McHugh JulieDirector
|
SaleClass A Common Stock | 1,500 | $12.46 | $18,690.00 |
DisclosureSEC source: 0001209191-18-061804 · doc4.xml · nonDerivative · entry 1 McHugh Julie · CIK 0001487179 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,631 F1 · kind: This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards. Read SEC document |
| December 06, 2018 Filed Dec 10, 2018 21:37 UTC |
OLANOFF LAWRENCE SDirector
|
SaleClass A Common Stock | 2,000 | $12.47 | $24,940.00 |
DisclosureSEC source: 0001209191-18-061788 · doc4.xml · nonDerivative · entry 1 OLANOFF LAWRENCE S · CIK 0001224341 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,553 F1 · kind: This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards. Read SEC document |
| November 09, 2018 Filed Nov 14, 2018 02:41 UTC |
Consylman GinaChief Financial Officer
|
SaleClass A Common Stock | 1,358 | $11.81 | $16,037.98 |
DisclosureSEC source: 0001209191-18-058419 · doc4.xml · nonDerivative · entry 1 Consylman Gina · CIK 0001546358 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,361 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on each of December 16, 2016 and January 2, 2018. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.64 to $12.03, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 05, 2018 Filed Oct 9, 2018 22:42 UTC |
Currie Mark GChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 41,615 | $0.00 Strike: $10.24 | $0.00 |
DisclosureSEC source: 0001209191-18-054598 · doc4.xml · derivative · entry 16 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,770 Underlying: Class A Common Stock · 41,615 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option, granted as an annual performance award, vests as to 2.08333% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2016. Read SEC document |
| October 05, 2018 Filed Oct 9, 2018 22:42 UTC |
Currie Mark GChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 34,480 | $0.00 Strike: $11.11 | $0.00 |
DisclosureSEC source: 0001209191-18-054598 · doc4.xml · derivative · entry 15 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,041 Underlying: Class A Common Stock · 34,480 shares Expires 2021-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option, granted as an annual performance award, vested as to 1.25% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2011 for the first 36 months, and as to 4.5833% of the shares of Class A Common Stock on each monthly anniversary thereafter. The option was fully vested as of January 1, 2015. Read SEC document |
| October 05, 2018 Filed Oct 9, 2018 22:42 UTC |
Currie Mark GChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 40,556 | $0.00 Strike: $11.25 | $0.00 |
DisclosureSEC source: 0001209191-18-054598 · doc4.xml · derivative · entry 14 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,888 Underlying: Class A Common Stock · 40,556 shares Expires 2020-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vested as to 1.25% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2010 for the first 36 months, and as to 4.5833% of the shares of Class A Common Stock on each monthly anniversary thereafter. The option was fully vested as of January 1, 2014. Read SEC document |
| October 05, 2018 Filed Oct 9, 2018 22:42 UTC |
Currie Mark GChief Scientific Officer
|
SaleClass A Common Stock | 116,651 | $17.53 | $2,044,892.03 |
DisclosureSEC source: 0001209191-18-054598 · doc4.xml · nonDerivative · entry 9 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,124 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.22 to $17.79, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 05, 2018 Filed Oct 9, 2018 22:42 UTC |
Currie Mark GChief Scientific Officer
|
Exercise / conversionClass A Common Stock | 41,615 | $10.24 | $426,137.60 |
DisclosureSEC source: 0001209191-18-054598 · doc4.xml · nonDerivative · entry 8 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,775 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 05, 2018 Filed Oct 9, 2018 22:42 UTC |
Currie Mark GChief Scientific Officer
|
Exercise / conversionClass A Common Stock | 34,480 | $11.11 | $383,072.80 |
DisclosureSEC source: 0001209191-18-054598 · doc4.xml · nonDerivative · entry 7 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,160 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 05, 2018 Filed Oct 9, 2018 22:42 UTC |
Currie Mark GChief Scientific Officer
|
Exercise / conversionClass A Common Stock | 40,556 | $11.25 | $456,255.00 |
DisclosureSEC source: 0001209191-18-054598 · doc4.xml · nonDerivative · entry 6 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 04, 2018 Filed Oct 9, 2018 22:42 UTC |
Currie Mark GChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 41,615 | $0.00 Strike: $10.24 | $0.00 |
DisclosureSEC source: 0001209191-18-054598 · doc4.xml · derivative · entry 13 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,385 Underlying: Class A Common Stock · 41,615 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option, granted as an annual performance award, vests as to 2.08333% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2016. Read SEC document |
| October 04, 2018 Filed Oct 9, 2018 22:42 UTC |
Currie Mark GChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 34,479 | $0.00 Strike: $11.11 | $0.00 |
DisclosureSEC source: 0001209191-18-054598 · doc4.xml · derivative · entry 12 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,521 Underlying: Class A Common Stock · 34,479 shares Expires 2021-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option, granted as an annual performance award, vested as to 1.25% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2011 for the first 36 months, and as to 4.5833% of the shares of Class A Common Stock on each monthly anniversary thereafter. The option was fully vested as of January 1, 2015. Read SEC document |
| October 04, 2018 Filed Oct 9, 2018 22:42 UTC |
Currie Mark GChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 40,556 | $0.00 Strike: $11.25 | $0.00 |
DisclosureSEC source: 0001209191-18-054598 · doc4.xml · derivative · entry 11 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,444 Underlying: Class A Common Stock · 40,556 shares Expires 2020-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vested as to 1.25% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2010 for the first 36 months, and as to 4.5833% of the shares of Class A Common Stock on each monthly anniversary thereafter. The option was fully vested as of January 1, 2014. Read SEC document |
| October 04, 2018 Filed Oct 9, 2018 22:42 UTC |
Currie Mark GChief Scientific Officer
|
SaleClass A Common Stock | 22,194 | $18.75 | $416,137.50 |
DisclosureSEC source: 0001209191-18-054598 · doc4.xml · nonDerivative · entry 5 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,124 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.37 to $19.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 04, 2018 Filed Oct 9, 2018 22:42 UTC |
Currie Mark GChief Scientific Officer
|
SaleClass A Common Stock | 94,456 | $17.94 | $1,694,540.64 |
DisclosureSEC source: 0001209191-18-054598 · doc4.xml · nonDerivative · entry 4 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,318 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.37 to $18.36, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 04, 2018 Filed Oct 9, 2018 22:42 UTC |
Currie Mark GChief Scientific Officer
|
Exercise / conversionClass A Common Stock | 41,615 | $10.24 | $426,137.60 |
DisclosureSEC source: 0001209191-18-054598 · doc4.xml · nonDerivative · entry 3 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,774 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 04, 2018 Filed Oct 9, 2018 22:42 UTC |
Currie Mark GChief Scientific Officer
|
Exercise / conversionClass A Common Stock | 34,479 | $11.11 | $383,061.69 |
DisclosureSEC source: 0001209191-18-054598 · doc4.xml · nonDerivative · entry 2 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,159 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 04, 2018 Filed Oct 9, 2018 22:42 UTC |
Currie Mark GChief Scientific Officer
|
Exercise / conversionClass A Common Stock | 40,556 | $11.25 | $456,255.00 |
DisclosureSEC source: 0001209191-18-054598 · doc4.xml · nonDerivative · entry 1 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:16 UTC |
MCGUIRE TERRANCEDirector
|
GrantClass A Common Stock | 136 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-051450 · doc4.xml · nonDerivative · entry 1 MCGUIRE TERRANCE · CIK 0001117003 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,291 F1 · kind: Issued pursuant to the Director Compensation Plan, effective as of January 2014. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:21 UTC |
SCHULMAN AMY WDirector
|
GrantClass A Common Stock | 136 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-051466 · doc4.xml · nonDerivative · entry 1 SCHULMAN AMY W · CIK 0001438226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,903 F1 · kind: Issued pursuant to the Director Compensation Plan, effective as of January 2014. Read SEC document |
| September 05, 2018 Filed Sep 7, 2018 20:01 UTC |
McHugh JulieDirector
|
SaleClass A Common Stock | 1,500 | $19.10 | $28,650.00 |
DisclosureSEC source: 0001209191-18-050030 · doc4.xml · nonDerivative · entry 1 McHugh Julie · CIK 0001487179 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,131 F1 · kind: This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.03 to $19.26, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 05, 2018 Filed Sep 7, 2018 20:01 UTC |
OLANOFF LAWRENCE SDirector
|
SaleClass A Common Stock | 2,000 | $19.10 | $38,200.00 |
DisclosureSEC source: 0001209191-18-050031 · doc4.xml · nonDerivative · entry 1 OLANOFF LAWRENCE S · CIK 0001224341 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,553 F1 · kind: This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.90 to $19.26, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 24, 2018 Filed Aug 28, 2018 20:03 UTC |
Currie Mark GChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 6,666 | $0.00 Strike: $5.48 | $0.00 |
DisclosureSEC source: 0001209191-18-048664 · doc4.xml · derivative · entry 8 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Class B Common Stock · 6,666 shares Expires 2019-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests in two equal installments based on the issuer's achievement of certain regulatory and commercial milestones. Upon achievement of a regulatory milestone, the option vested as to 20,000 shares of Class B Common Stock on January 4, 2017. Read SEC document |
| August 24, 2018 Filed Aug 28, 2018 20:03 UTC |
Currie Mark GChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 41,667 | $0.00 Strike: $4.89 | $0.00 |
DisclosureSEC source: 0001209191-18-048664 · doc4.xml · derivative · entry 7 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 41,667 shares Expires 2019-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested as to 1.25% of the shares of Class B Common Stock on each monthly anniversary of January 1, 2009 for the first 36 months, and as to 4.5833% of the shares of Class B Common Stock on each monthly anniversary thereafter. The option was fully vested as of January 1, 2013. Read SEC document |
| August 24, 2018 Filed Aug 28, 2018 20:03 UTC |
Currie Mark GChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 16,667 | $0.00 Strike: $4.89 | $0.00 |
DisclosureSEC source: 0001209191-18-048664 · doc4.xml · derivative · entry 6 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 16,667 shares Expires 2019-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option was fully vested as of its grant date of February 12, 2009. Read SEC document |
| August 24, 2018 Filed Aug 28, 2018 20:03 UTC |
Currie Mark GChief Scientific Officer
|
SaleClass B Common Stock | 65,000 | $18.39 | $1,195,350.00 |
DisclosureSEC source: 0001209191-18-048664 · doc4.xml · nonDerivative · entry 4 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 775,000 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. In order to effect the sale, these shares of Class B Common Stock were converted into shares of Class A Common Stock in accordance with the issuer's certificate of incorporation. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.21 to $18.65, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 24, 2018 Filed Aug 28, 2018 20:03 UTC |
Currie Mark GChief Scientific Officer
|
Exercise / conversionClass B Common Stock | 6,666 | $5.48 | $36,529.68 |
DisclosureSEC source: 0001209191-18-048664 · doc4.xml · nonDerivative · entry 3 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 840,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 24, 2018 Filed Aug 28, 2018 20:03 UTC |
Currie Mark GChief Scientific Officer
|
Exercise / conversionClass B Common Stock | 41,667 | $4.89 | $203,751.63 |
DisclosureSEC source: 0001209191-18-048664 · doc4.xml · nonDerivative · entry 2 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 833,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 24, 2018 Filed Aug 28, 2018 20:03 UTC |
Currie Mark GChief Scientific Officer
|
Exercise / conversionClass B Common Stock | 16,667 | $4.89 | $81,501.63 |
DisclosureSEC source: 0001209191-18-048664 · doc4.xml · nonDerivative · entry 1 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 791,667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2018 Filed Aug 24, 2018 21:21 UTC |
Currie Mark GChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 6,667 | $0.00 Strike: $5.48 | $0.00 |
DisclosureSEC source: 0001209191-18-048410 · doc4.xml · derivative · entry 15 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,666 Underlying: Class B Common Stock · 6,667 shares Expires 2019-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vests in two equal installments based on the issuer's achievement of certain regulatory and commercial milestones. Upon achievement of a regulatory milestone, the option vested as to 20,000 shares of Class B Common Stock on January 4, 2017. Read SEC document |
| August 23, 2018 Filed Aug 24, 2018 21:21 UTC |
Currie Mark GChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 41,666 | $0.00 Strike: $4.89 | $0.00 |
DisclosureSEC source: 0001209191-18-048410 · doc4.xml · derivative · entry 14 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,667 Underlying: Class B Common Stock · 41,666 shares Expires 2019-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vested as to 1.25% of the shares of Class B Common Stock on each monthly anniversary of January 1, 2009 for the first 36 months, and as to 4.5833% of the shares of Class B Common Stock on each monthly anniversary thereafter. The option was fully vested as of January 1, 2013. Read SEC document |
| August 23, 2018 Filed Aug 24, 2018 21:21 UTC |
Currie Mark GChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 16,667 | $0.00 Strike: $4.89 | $0.00 |
DisclosureSEC source: 0001209191-18-048410 · doc4.xml · derivative · entry 13 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,667 Underlying: Class B Common Stock · 16,667 shares Expires 2019-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option was fully vested as of its grant date of February 12, 2009. Read SEC document |
| August 23, 2018 Filed Aug 24, 2018 21:21 UTC |
Currie Mark GChief Scientific Officer
|
SaleClass B Common Stock | 65,000 | $18.39 | $1,195,350.00 |
DisclosureSEC source: 0001209191-18-048410 · doc4.xml · nonDerivative · entry 8 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 775,000 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. In order to effect the sale, these shares of Class B Common Stock were converted into shares of Class A Common Stock in accordance with the issuer's certificate of incorporation. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.18 to $18.63, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 23, 2018 Filed Aug 24, 2018 21:21 UTC |
Currie Mark GChief Scientific Officer
|
Exercise / conversionClass B Common Stock | 6,667 | $5.48 | $36,535.16 |
DisclosureSEC source: 0001209191-18-048410 · doc4.xml · nonDerivative · entry 7 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 840,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2018 Filed Aug 24, 2018 21:21 UTC |
Currie Mark GChief Scientific Officer
|
Exercise / conversionClass B Common Stock | 41,666 | $4.89 | $203,746.74 |
DisclosureSEC source: 0001209191-18-048410 · doc4.xml · nonDerivative · entry 6 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 833,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2018 Filed Aug 24, 2018 21:21 UTC |
Currie Mark GChief Scientific Officer
|
Exercise / conversionClass B Common Stock | 16,667 | $4.89 | $81,501.63 |
DisclosureSEC source: 0001209191-18-048410 · doc4.xml · nonDerivative · entry 5 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 791,667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 22, 2018 Filed Aug 24, 2018 21:21 UTC |
Currie Mark GChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 6,667 | $0.00 Strike: $5.48 | $0.00 |
DisclosureSEC source: 0001209191-18-048410 · doc4.xml · derivative · entry 12 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,333 Underlying: Class B Common Stock · 6,667 shares Expires 2019-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vests in two equal installments based on the issuer's achievement of certain regulatory and commercial milestones. Upon achievement of a regulatory milestone, the option vested as to 20,000 shares of Class B Common Stock on January 4, 2017. Read SEC document |
| August 22, 2018 Filed Aug 24, 2018 21:21 UTC |
Currie Mark GChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 41,667 | $0.00 Strike: $4.89 | $0.00 |
DisclosureSEC source: 0001209191-18-048410 · doc4.xml · derivative · entry 11 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,333 Underlying: Class B Common Stock · 41,667 shares Expires 2019-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vested as to 1.25% of the shares of Class B Common Stock on each monthly anniversary of January 1, 2009 for the first 36 months, and as to 4.5833% of the shares of Class B Common Stock on each monthly anniversary thereafter. The option was fully vested as of January 1, 2013. Read SEC document |
| August 22, 2018 Filed Aug 24, 2018 21:21 UTC |
Currie Mark GChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 16,666 | $0.00 Strike: $4.89 | $0.00 |
DisclosureSEC source: 0001209191-18-048410 · doc4.xml · derivative · entry 10 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,334 Underlying: Class B Common Stock · 16,666 shares Expires 2019-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option was fully vested as of its grant date of February 12, 2009. Read SEC document |
| August 22, 2018 Filed Aug 24, 2018 21:21 UTC |
Currie Mark GChief Scientific Officer
|
SaleClass B Common Stock | 65,000 | $18.51 | $1,203,150.00 |
DisclosureSEC source: 0001209191-18-048410 · doc4.xml · nonDerivative · entry 4 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 775,000 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. In order to effect the sale, these shares of Class B Common Stock were converted into shares of Class A Common Stock in accordance with the issuer's certificate of incorporation. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.18 to $18.66, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 22, 2018 Filed Aug 24, 2018 21:21 UTC |
Currie Mark GChief Scientific Officer
|
Exercise / conversionClass B Common Stock | 6,667 | $5.48 | $36,535.16 |
DisclosureSEC source: 0001209191-18-048410 · doc4.xml · nonDerivative · entry 3 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 840,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 22, 2018 Filed Aug 24, 2018 21:21 UTC |
Currie Mark GChief Scientific Officer
|
Exercise / conversionClass B Common Stock | 41,667 | $4.89 | $203,751.63 |
DisclosureSEC source: 0001209191-18-048410 · doc4.xml · nonDerivative · entry 2 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 833,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 22, 2018 Filed Aug 24, 2018 21:21 UTC |
Currie Mark GChief Scientific Officer
|
Exercise / conversionClass B Common Stock | 16,666 | $4.89 | $81,496.74 |
DisclosureSEC source: 0001209191-18-048410 · doc4.xml · nonDerivative · entry 1 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 791,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2018 Filed Aug 24, 2018 21:18 UTC |
Owens Edward PDirector
|
GiftClass A Common Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-048406 · doc4.xml · nonDerivative · entry 2 Owens Edward P · CIK 0001570533 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Owens Family Foundation Disclosed balance after: 40,000 F1 · ownership.nature: The reporting person and certain members of his family are trustees of the foundation, the beneficial owner of the securities. The reporting person disclaims beneficial ownership of the securities. Read SEC document |
| August 20, 2018 Filed Aug 24, 2018 21:18 UTC |
Owens Edward PDirector
|
GiftClass A Common Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-048406 · doc4.xml · nonDerivative · entry 1 Owens Edward P · CIK 0001570533 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,528 Read SEC document |
| August 17, 2018 Filed Aug 21, 2018 20:57 UTC |
Consylman GinaChief Financial Officer
|
SaleClass A Common Stock | 188 | $18.21 | $3,423.48 |
DisclosureSEC source: 0001209191-18-047765 · doc4.xml · nonDerivative · entry 1 Consylman Gina · CIK 0001546358 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,719 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on September 16, 2015. Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 22:01 UTC |
Currie Mark GChief Scientific Officer
|
GrantClass A Common Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-045056 · doc4.xml · nonDerivative · entry 1 Currie Mark G · CIK 0001478244 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,124 F1 · kind: The restricted stock unit award, granted as a recognition award, vests as to 100% of the shares of Class A Common Stock on May 9, 2019. Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 17:56 UTC |
MCCOURT Thomas AChief Commercial Officer
|
GrantClass A Common Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-045051 · doc4.xml · nonDerivative · entry 1 MCCOURT Thomas A · CIK 0001478448 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,150 F1 · kind: The restricted stock unit award, granted as a recognition award, vests as to 100% of the shares of Class A Common Stock on May 9, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.